Wednesday, 21 August 2019

Pharma News

  • NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, anti-infective products for the treatment and prevention of topical infe...Read more

  • Frost & Sullivan awards life science leaders

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Mumbai: The 4th Annual Frost & Sullivan India Healthcare Excellence Awards 2012, were held in Mumbai to recognize companies that showed innovative growth strategies and solutions in the...Read more

  • Biostar signs another $3 mn military contract within a month

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2012

    Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to manufacture and supply Xijing Hospital with five additional drugs. Spec...Read more

  • FDA warns Genentech researcher for trial data validity

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular degeneration treatment, for failing to follow the protocol and maintai...Read more

  • Medigene, SynCore expand deal for Veregen

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 20 Mar, 2013

    Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expanded the existing exclusive licensing and supply contract into new re...Read more

  • Ranbaxy may fire 1/3rd of its global sales staff

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2013

    Singapore: Ranbaxy Laboratories is contemplating on slashing its global sales staff by about a third, with a majority of the job cuts expected to be in the US, according to a report by Busi...Read more

  • Aus, NZ progress on joint regulatory agency

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic Products Agency (ANZTPA) implementation ministerial council in a con...Read more

  • Now 9-yr-old girls can use Cervarix for cancer

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, premalignant cervical lesions and cervical cancer caused by Human Papillo...Read more

  • Hiring freeze in pharma industry

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Sep, 2012

    New Delhi: The overall economic crunch has resulted in companies adopting a cautious approach in their hiring plans. Naukri.com, a major job site in India, in its survey on the pharma secto...Read more

  • Sucampo, Abbott launch Amitiza in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Singapore: Sucampo Pharmaceuticals and Abbott have launched Amitiza (lubiprostone) in Japan, a prescription medicine for the treatment of chronic constipation not caused by organic diseases...Read more

  • India clears Mylan's $760 mn acquisition deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2013

    Singapore: The Indian Cabinet Committee on Economic Affairs (CCEA) gave its final clearance to US-based Mylan to acquire Indian company Agila Specialties on September 3. The $760 million ac...Read more

  • Xiangxue Pharma acquires rights for Kinex KX02

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceuticals exclusive rights to Kinex's KX02 for all oncology indications i...Read more

  • Lipitor leads in Australia

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market followed by China. According to BioSpectrum Top20 survey for the Asia Pa...Read more

  • Chinese, Hong Kong scientists map H7N9 risk infection

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

    Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption, which can be used to determine future risk and advis...Read more

  • AstraZeneca, Alchemia sign $240 mn drug deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

    Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the use of the proprietary Diversity Scanning Array (DSA) and associated...Read more

  • Merck shuts 2 sites, to further axe 1,100 staff

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: Merck plans to terminate around 1,100 of its 10,900 staff  in Germany by the end of 2015. Merck signed an agreement with employee representatives on an efficiency plan for the c...Read more

  • India's Orchid Pharma completes debt recast

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    Singapore: Indian company, based in Chennai, Orchid Chemicals and Pharmaceuticals has said that it completed the debt recast scheme that it had initiated last year. As per the process, Orc...Read more

  • Lilly reveals phase III trial data on back pain

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rDNA origin injection) and risedronate on back pain in postmenopausal w...Read more



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls